TFF Pharmaceuticals, Inc.
TFFP · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -70.3% | 219.9% | -72.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 78.4% | 31% | 82.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,852.3% | -587.8% | -2,752.4% | -713.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,833.1% | -688.9% | -2,821.4% | -648.9% |
| EPS Diluted | -0.81 | -1.22 | -2.4 | -2.01 |
| % Growth | 33.6% | 49.2% | -19.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |